Imunon Inc (IMNN)

Imunon Inc (IMNN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $6.1M; returns 1 day -1.2%, 1 week +21.1%, 1 year -74.8%.

Imunon Inc. (IMNN) is a clinical-stage biotechnology company focused on developing immunotherapies and vaccines, primarily utilizing non-viral DNA technology. Their lead clinical program is IMNN-001, a DNA-based immunotherapy for advanced ovarian cancer, currently in Phase 3 clinical development (OVATION 3 trial).

Groups IMNN belongs to

• Clinical Stage Biotech
• Biotechnology
• Immunotherapy
• Healthcare
• Clinical Stage
• Ovarian Cancer
• Oncology
• Cancer Therapeutics
• Biopharmaceutical
• Life Sciences
• R&D
• Infectious Diseases

IMNN financial model: income statement, cash flow and balance sheet